Ultragenyx Pharmaceutical shares owned by UBS Group
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Ultragenyx Pharmaceutical by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $14M | 326k | 42.07 |
2024-09-30 | $5.2M | 93k | 55.55 |
2024-06-30 | $8.1M | 196k | 41.10 |
2024-03-31 | $7.9M | 169k | 46.69 |
2023-12-31 | $2.8M | 58k | 47.82 |
2023-09-30 | $1.7M | 46k | 35.65 |
2023-06-30 | $2.9M | 64k | 46.14 |
2023-03-31 | $3.0M | 75k | 40.10 |
2022-12-31 | $7.6M | 165k | 46.33 |
2022-09-30 | $1.3M | 30k | 42.55 |
2022-06-30 | $2.8M | 47k | 59.65 |
2022-03-31 | $6.4M | 92k | 69.31 |
2021-12-31 | $5.3M | 63k | 84.09 |
2021-09-30 | $5.1M | 56k | 90.19 |
2021-06-30 | $2.4M | 26k | 95.33 |
2021-03-31 | $5.7M | 50k | 113.88 |
2020-12-31 | $3.8M | 28k | 139.18 |
2020-09-30 | $2.2M | 26k | 82.20 |
2020-06-30 | $2.5M | 32k | 78.24 |
2020-03-31 | $5.8M | 131k | 44.43 |
2019-12-31 | $3.5M | 82k | 42.71 |
2019-09-30 | $7.0M | 164k | 42.78 |
2019-06-30 | $2.5M | 40k | 63.50 |
2019-03-31 | $2.0M | 28k | 69.19 |
2018-12-31 | $6.5M | 150k | 43.48 |
2018-09-30 | $3.2M | 41k | 76.33 |
2018-06-30 | $2.1M | 28k | 75.47 |
2018-03-31 | $5.8M | 114k | 51.00 |
2017-12-31 | $1.1M | 24k | 46.41 |
2017-09-30 | $1.9M | 35k | 53.26 |
2017-06-30 | $1.1M | 17k | 62.06 |
2017-03-31 | $658k | 9.7k | 67.74 |
2016-12-31 | $3.3M | 47k | 70.31 |
2016-09-30 | $2.1M | 30k | 70.93 |
2016-06-30 | $1.3M | 27k | 48.00 |
2016-03-31 | $830k | 13k | 62.50 |
2015-12-31 | $1.9M | 17k | 112.15 |
2015-09-30 | $988k | 10k | 97.50 |
2015-03-31 | $1.5M | 25k | 62.50 |